Haypp Q2 FY26 EBIT drops 13.46% to SEK 9 million; net sales rise 28% to SEK 1.18 billion
Reuters2026/08/12 16:07- Haypp Group net sales climbed 28% year over year to SEK 1.18 billion in April-June 2026; organic growth was 27%.
- EBITDA rose to SEK 45.7 million; the margin narrowed 0.7 percentage points to 3.9%.
- Profit for the quarter turned to breakeven at SEK 0.0 million; earnings per share were SEK 0.00.
- Nicotine pouch volumes grew 45% year over year; nicotine pouches represented 71% of group volume.
- Orders increased to 1,445,000; active consumers rose to 667,000 as US and UK volumes more than doubled year over year.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
